tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

GB:AVCT Stock Latest News

Avacta Reports Positive Phase 1a Results for AVA6000 in Salivary Gland Cancer
Company AnnouncementsAvacta Reports Positive Phase 1a Results for AVA6000 in Salivary Gland Cancer
3d ago
Avacta Group Appoints New CFO to Drive Strategic Growth
PremiumCompany Announcements
Avacta Group Appoints New CFO to Drive Strategic Growth
6d ago
Avacta Group Opens Phase 1b Trial for Targeted Cancer Therapy
PremiumCompany Announcements
Avacta Group Opens Phase 1b Trial for Targeted Cancer Therapy
1M ago
Avacta Group Advances with Targeted Cancer Therapies
PremiumCompany Announcements
Avacta Group Advances with Targeted Cancer Therapies
3M ago
Avacta Group Unveils Promising Cancer Therapy Advances
PremiumCompany Announcements
Avacta Group Unveils Promising Cancer Therapy Advances
3M ago
Avacta Group PLC Issues New Shares Amid Strategic Shift
PremiumCompany AnnouncementsAvacta Group PLC Issues New Shares Amid Strategic Shift
3M ago
Avacta Collaborates with Tempus AI for Cancer Drug Development
Premium
Company Announcements
Avacta Collaborates with Tempus AI for Cancer Drug Development
3M ago
Avacta Group Expands Oncology Pipeline with Novel Assets
Premium
Company Announcements
Avacta Group Expands Oncology Pipeline with Novel Assets
3M ago
Avacta Appoints New Chief Scientific Officer
PremiumCompany Announcements
Avacta Appoints New Chief Scientific Officer
3M ago
Avacta Reveals Breakthroughs in Targeted Cancer Therapies
PremiumCompany Announcements
Avacta Reveals Breakthroughs in Targeted Cancer Therapies
3M ago
Avacta Reports Encouraging AVA6000 Trial Results
PremiumCompany Announcements
Avacta Reports Encouraging AVA6000 Trial Results
4M ago
Avacta’s AVA6000 Shows Promise in Phase 1 Trial
PremiumCompany Announcements
Avacta’s AVA6000 Shows Promise in Phase 1 Trial
4M ago
Avacta Group Announces Upcoming Interim Results
PremiumCompany AnnouncementsAvacta Group Announces Upcoming Interim Results
4M ago
Avacta Reveals Promising AVA6000 Trial Data at ESMO
Premium
Company Announcements
Avacta Reveals Promising AVA6000 Trial Data at ESMO
4M ago
Avacta Group Announces Executive Share Options
Premium
Company Announcements
Avacta Group Announces Executive Share Options
5M ago
Avacta Settles Bond Payment in Cash, On Track for 2024 Goals
PremiumCompany Announcements
Avacta Settles Bond Payment in Cash, On Track for 2024 Goals
6M ago
Avacta Group’s AGM Success and Clinical Advances
PremiumCompany Announcements
Avacta Group’s AGM Success and Clinical Advances
7M ago
Avacta Advances Cancer Drug Trial, Strengthens Board
PremiumCompany Announcements
Avacta Advances Cancer Drug Trial, Strengthens Board
7M ago
Avacta Group Appoints New Chairman, Eyes Growth
PremiumCompany Announcements
Avacta Group Appoints New Chairman, Eyes Growth
7M ago
Avacta Engages Peel Hunt as New Adviser
PremiumCompany AnnouncementsAvacta Engages Peel Hunt as New Adviser
7M ago
Avacta Group Announces AGM and Yearly Report
Premium
Company Announcements
Avacta Group Announces AGM and Yearly Report
8M ago
Avacta Advances Oncology Program with AVA6000 Trial
Premium
Company Announcements
Avacta Advances Oncology Program with AVA6000 Trial
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >